GADVEN owner Contact Information online
from Glaxo Group Limited
GADVEN
US serial number:85182481
Application filling date:Nov. 22, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jul. 14, 2014
Publication date:Apr. 12, 2011
Abandoned date:Jul. 14, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive
Current owner owner name:Glaxo Group Limited
Current owner owner address:980 Great West Road
Brentford, Middlesex
UNITED KINGDOM
TW89GS
Current owner legal entity type:CORPORATION
Current owner state or country:UNITED KINGDOM
Attorney name:Christopher M. Hanes
Attorney email:trademarks@gsk.com
Attorney docket number:PRJ/7056097/
Attorney email authorized:Yes
Correspondent name address:Christopher M. Hanes
GlaxoSmithKline
Five Moore Drive
LGTM, C.3157.3D
Research Triangle Park,
NORTH CAROLINA
UNITED STATES
27709
Correspondent phone:919 483 2723
Correspondent email:trademarks@gsk.com
Correspondent fax:704 625 9190
Correspondent email authorized:Yes
Domestic representative name:Christopher M. Hanes
Domestic representative phone:919 483 2723
Domestic representative fax:704 625 9190
Domestic representative email:trademarks@gsk.com
Domestic representative email authorized:Yes
Trademark staff tm attorney:YARD, JOHN S
Trademark staff law office assigned GADVEN:LAW OFFICE 115
Latest trademarks
Popular owners
Glaxo Group Limited (178) Novartis AG (131) JOHNSON & JOHNSON (126) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) SANOFI (46) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) Wyeth LLC (41) Pfizer Inc. (39) Bristol-Myers Squibb Company (37) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Ares Trading S.A. (17) Scott Riddell (17)Popular publication dates
Apr. 12, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Mar. 29, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
